Literature DB >> 18163499

Association of microsomal prostaglandin E synthase 1 deficiency with impaired fracture healing, but not with bone loss or osteoarthritis, in mouse models of skeletal disorders.

Kiyofumi Yamakawa1, Satoru Kamekura, Naohiro Kawamura, Masatomo Saegusa, Daisuke Kamei, Makoto Murakami, Ichiro Kudo, Satoshi Uematsu, Shizuo Akira, Ung-il Chung, Kozo Nakamura, Hiroshi Kawaguchi.   

Abstract

OBJECTIVE: Prostaglandin E synthase (PGES) functions as the terminal enzyme in the biosynthesis of prostaglandin E(2) (PGE(2)) and is a potent regulator of bone and cartilage metabolism. Among the 3 isozymes of PGES, microsomal PGES-1 (mPGES-1) is known to play the most critical role in the production of PGE(2) in pathophysiologic events. This study investigated the roles of mPGES-1 under normal physiologic and pathophysiologic conditions in the skeletons of mPGES-1-deficient (mPGES-1(-/-)) mice.
METHODS: Skeletons of mPGES-1(-/-) mice and their wild-type littermates were compared by radiologic and histologic analyses. Four models of skeletal disorders were created: bone loss induced by ovariectomy, bone loss induced by hind limb unloading, osteoarthritis (OA) induced by instability in the knee joint, and bone fracture by osteotomy at the tibial midshaft. Expression of the PGES enzymes was examined by immunohistochemistry and real-time reverse transcription-polymerase chain reaction. The cellular mechanism of fracture healing was examined in ex vivo cultures of costal cartilage chondrocytes.
RESULTS: Microsomal PGES-1(-/-) mice had unaffected skeletal phenotypes under normal physiologic conditions. In the bone fracture model, fracture healing was impaired by the mPGES-1 deficiency, with half of the mice remaining in a non-bone union state even after 21 days; normal fracture healing was restored by adenoviral reintroduction of mPGES-1. The other skeletal disorders were not affected by the mPGES-1 deficiency. In vivo and ex vivo analyses revealed an impaired proliferation of chondrocytes in cartilage with the mPGES-1 deficiency, at an early stage of fracture healing.
CONCLUSION: In these mouse models of skeletal disorders, mPGES-1 was indispensable for bone repair through chondrocyte proliferation, but was not essential for the skeleton under normal physiologic conditions, nor did it play a role in the pathophysiologic conditions of bone loss due to ovariectomy, bone loss due to unloading, or stress-induced OA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18163499     DOI: 10.1002/art.23158

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  4 in total

Review 1.  Harnessing and modulating inflammation in strategies for bone regeneration.

Authors:  Paschalia M Mountziaris; Patrick P Spicer; F Kurtis Kasper; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2011-06-30       Impact factor: 6.389

Review 2.  Fracture healing and lipid mediators.

Authors:  J Patrick O'Connor; Michaele B Manigrasso; Brian D Kim; Sangeeta Subramanian
Journal:  Bonekey Rep       Date:  2014-04-02

3.  Prostaglandin E2 inhibits matrix mineralization by human bone marrow stromal cell-derived osteoblasts via Epac-dependent cAMP signaling.

Authors:  Ali Mirsaidi; André N Tiaden; Peter J Richards
Journal:  Sci Rep       Date:  2017-05-22       Impact factor: 4.379

4.  NSAIDS inhibit in vitro MSC chondrogenesis but not osteogenesis: implications for mechanism of bone formation inhibition in man.

Authors:  Ippokratis Pountos; Peter V Giannoudis; Elena Jones; Anne English; Sarah Churchman; Sarah Field; Frederique Ponchel; Howard Bird; Paul Emery; Dennis McGonagle
Journal:  J Cell Mol Med       Date:  2011-03       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.